Revolutionizing Therapeutic Applications of Natural Biopolymers for Drug/Gene Delivery

A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".

Deadline for manuscript submissions: closed (31 December 2023) | Viewed by 2454

Special Issue Editor


E-Mail Website
Guest Editor
Department of Administrative and Pharmaceutical Sciences, University of Health Science and Pharmacy in St. Louis, St. Louis, MO 63110, USA
Interests: drug delivery; nanoparticles; nanomedicine; tissue-specific targeting; tumor targeting
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Natural biopolymers are promising candidates for revolutionizing the therapeutic applications of drug and gene delivery owing to their numerous advantages, including, but not limited to, low immunogenicity, biocompatibility, and biodegradability. Traditional delivery systems often face limitations such as poor bioavailability, rapid clearance, and off-target effects when applied to drug and gene delivery in order to specific target sites. Natural biopolymers, derived from biological sources such as proteins, polysaccharides, and nucleic acids, offer a promising alternative for overcoming these challenges. Additionally, the ability to engineer these biopolymers in order to respond to specific environmental cues, such as pH, temperature, or enzymatic activity, can enhance site-specific drug release and improve the efficiency of gene transfection. By regulating the inherent properties of these biopolymers, advanced delivery platforms could be designed with enhanced efficacy and reduced toxicity.

The ability of natural biopolymers to self-assemble into nanoparticles, micelles, hydrogels, and other carrier systems enables the controlled release of therapeutic agents. These biopolymers can also be functionalized using targeting ligands, enabling site-specific drug delivery, minimizing off-target effects, and augmenting their therapeutic efficiency.

Natural biopolymers, such as DNA and RNA-based polymers, are excellent candidates for delivering genetic material into target cells. Their biocompatibility and ability to protect nucleic acids from enzymatic degradation are critical factors in successful gene delivery. The applicability of these natural biopolymers could be enhanced by modifying biopolymers so as to boost cellular uptake and endosomal escape.

This Special Issue aims to provide an overview of the recent advancements made with regard to utilizing natural biopolymers for drug and gene delivery, highlighting their potential to address existing challenges in conventional delivery systems and pave the way for personalized and targeted therapies.

Dr. Pankaj Dwivedi
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • natural biopolymers
  • drug delivery
  • gene delivery
  • targeted therapies
  • controlled release
  • nanoparticles
  • personalized medicine

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

22 pages, 5522 KiB  
Review
Natural Biopolymer-Based Delivery of CRISPR/Cas9 for Cancer Treatment
by Meng Lin and Xueyan Wang
Pharmaceutics 2024, 16(1), 62; https://doi.org/10.3390/pharmaceutics16010062 - 30 Dec 2023
Cited by 2 | Viewed by 1924
Abstract
Over the last decade, the clustered, regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) system has become the most promising gene editing tool and is broadly utilized to manipulate the gene for disease treatment, especially for cancer, which involves multiple genetic alterations. [...] Read more.
Over the last decade, the clustered, regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) system has become the most promising gene editing tool and is broadly utilized to manipulate the gene for disease treatment, especially for cancer, which involves multiple genetic alterations. Typically, CRISPR/Cas9 machinery is delivered in one of three forms: DNA, mRNA, or ribonucleoprotein. However, the lack of efficient delivery systems for these macromolecules confined the clinical breakthrough of this technique. Therefore, a variety of nanomaterials have been fabricated to improve the stability and delivery efficiency of the CRISPR/Cas9 system. In this context, the natural biopolymer-based carrier is a particularly promising platform for CRISPR/Cas9 delivery due to its great stability, low toxicity, excellent biocompatibility, and biodegradability. Here, we focus on the advances of natural biopolymer-based materials for CRISPR/Cas9 delivery in the cancer field and discuss the challenges for their clinical translation. Full article
Show Figures

Figure 1

Back to TopTop